Cash flow Eastman Chemical Company

Equities

EMN

US2774321002

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:02 2026-02-06 pm EST			5-day change	1st Jan Change
77.43 ^USD	+1.77%		+11.70%	+21.31%

Feb. 04	RBC Raises Price Target on Eastman Chemical to $79 From $70, Keeps Sector Perform Rating	MT
Feb. 02	Deutsche Bank Raises Price Target on Eastman Chemical to $72 From $64, Keeps Hold Rating	MT

6aae4aa731b3eb55b29c7349862.OmyzRXSmDV-IuJo8xqGrIxPa8JuFDsJrl5neftx7zYk.DzuCLwzhWjTfwa8JjtbJTWKvncG3eJ0MxKqESJ4aqcRqAtYsMM9nOrrCyw

Published financial data: EASTMAN CHEMICAL COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.47B	10.48B	10.58B	9.21B	9.38B
Total Revenues	8.47B	10.48B	10.58B	9.21B	9.38B
Cost of Goods Sold, Total	6.49B	7.97B	8.4B	7.13B	7.08B
Gross Profit	1.98B	2.5B	2.18B	2.08B	2.3B
Selling General & Admin Expenses, Total	773M	383M	625M	768M	664M
R&D Expenses	226M	254M	264M	239M	250M
Other Operating Expenses, Total	999M	637M	889M	1.01B	914M
Operating Income	984M	1.87B	1.29B	1.07B	1.38B
Interest Expense, Total	-214M	-201M	-188M	-225M	-216M
Interest And Investment Income	4M	3M	6M	10M	16M
Net Interest Expenses	-210M	-198M	-182M	-215M	-200M
Income (Loss) On Equity Invest.	15M	16M	19M	10M	-
Currency Exchange Gains (Loss)	-16M	-10M	-16M	-11M	-11M
Other Non Operating Income (Expenses)	-7M	11M	-3M	-37M	-36M
EBT, Excl. Unusual Items	766M	1.69B	1.1B	816M	1.14B
Restructuring Charges	-110M	-48M	-52M	-60M	-58M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-552M	-43M	323M	-
Asset Writedown	-125M	-3M	-	-	-
Insurance Settlements	-	-	-	8M	-
Other Unusual Items	-1M	-1M	-33M	-	-
EBT, Incl. Unusual Items	530M	1.08B	977M	1.09B	1.08B
Income Tax Expense	41M	215M	181M	191M	170M
Earnings From Continuing Operations	489M	867M	796M	896M	908M
Net Income to Company	489M	867M	796M	896M	908M
Minority Interest	-11M	-10M	-3M	-2M	-3M
Net Income - (IS)	478M	857M	793M	894M	905M
Net Income to Common Incl Extra Items	478M	857M	793M	894M	905M
Net Income to Common Excl. Extra Items	478M	857M	793M	894M	905M
Per Share Items
Net EPS - Basic	3.53	6.35	6.42	7.54	7.75
Basic EPS - Continuing Operations	3.53	6.35	6.42	7.54	7.75
Basic Weighted Average Shares Outstanding	136M	135M	124M	119M	117M
Net EPS - Diluted	3.5	6.25	6.35	7.49	7.67
Diluted EPS - Continuing Operations	3.5	6.25	6.35	7.49	7.67
Diluted Weighted Average Shares Outstanding	136M	137M	125M	119M	118M
Normalized Basic EPS	3.45	7.74	5.57	4.28	6.06
Normalized Diluted EPS	3.43	7.61	5.51	4.25	6
Dividend Per Share	2.67	2.83	3.07	3.18	3.26
Payout Ratio	74.9	43.76	48.05	42.06	41.88
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.55B	2.4B	1.76B	1.54B	1.89B
EBITA	1.11B	1.98B	1.37B	1.16B	1.46B
EBIT	984M	1.87B	1.29B	1.07B	1.38B
EBITDAR	1.66B	2.51B	1.86B	1.65B	2B
Effective Tax Rate - (Ratio)	7.74	19.87	18.53	17.57	15.77
Current Domestic Taxes	75M	138M	212M	140M	46M
Current Foreign Taxes	77M	115M	105M	153M	176M
Total Current Taxes	152M	253M	317M	293M	222M
Deferred Domestic Taxes	-97M	4M	-126M	-67M	-93M
Deferred Foreign Taxes	-14M	-42M	-10M	-35M	41M
Total Deferred Taxes	-111M	-38M	-136M	-102M	-52M
Normalized Net Income	468M	1.04B	688M	508M	707M
Interest Capitalized	4M	5M	9M	18M	17M
Non-Cash Pension Expense	94M	-347M	23M	60M	-66M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	226M	254M	264M	239M	250M
Net Rental Expense, Total	106M	107M	99M	105M	106M
Imputed Operating Lease Interest Expense	31.26M	31.43M	29.1M	39.91M	39.02M
Imputed Operating Lease Depreciation	74.74M	75.57M	69.9M	65.09M	66.98M
Stock-Based Comp., SG&A Exp. (Total)	44M	70M	69M	65M	63M
Total Stock-Based Compensation	44M	70M	69M	65M	63M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	564M	459M	493M	548M	837M
Trading Asset Securities, Total	1M	21M	1M	1M	19M
Total Cash And Short Term Investments	565M	480M	494M	549M	856M
Accounts Receivable, Total	1.1B	1.17B	1.05B	906M	883M
Other Receivables	420M	407M	227M	248M	289M
Total Receivables	1.52B	1.58B	1.28B	1.15B	1.17B
Inventory	1.38B	1.5B	1.89B	1.68B	1.99B
Other Current Assets, Total	82M	1.08B	113M	95M	85M
Total Current Assets	3.54B	4.65B	3.78B	3.48B	4.1B
Gross Property Plant And Equipment	13.71B	12.9B	13.15B	13.75B	14.15B
Accumulated Depreciation	-7.98B	-7.68B	-7.78B	-8.03B	-8.37B
Net Property Plant And Equipment	5.72B	5.21B	5.37B	5.73B	5.78B
Long-term Investments	156M	137M	183M	124M	183M
Goodwill	4.46B	3.64B	3.66B	3.65B	3.63B
Other Intangibles, Total	1.79B	1.36B	1.21B	1.14B	1.03B
Deferred Tax Assets Long-Term	112M	116M	123M	156M	109M
Other Long-Term Assets, Total	292M	405M	338M	360M	377M
Total Assets	16.08B	15.52B	14.67B	14.63B	15.21B
Liabilities
Accounts Payable, Total	799M	1.23B	1.32B	1.17B	1.31B
Accrued Expenses, Total	366M	381M	329M	405M	231M
Short-term Borrowings	50M	-	326M	-	-
Current Portion of Long-Term Debt	299M	747M	800M	541M	454M
Current Portion of Leases	56M	50M	52M	52M	49M
Current Income Taxes Payable	178M	138M	95M	133M	290M
Other Current Liabilities	290M	427M	330M	275M	375M
Total Current Liabilities	2.04B	2.97B	3.25B	2.58B	2.71B
Long-Term Debt	5.32B	4.42B	4.02B	4.37B	4.62B
Long-Term Leases	123M	157M	150M	120M	96M
Pension & Other Post Retirement Benefits	1.14B	811M	628M	667M	630M
Deferred Tax Liability Non Current	848M	810M	671M	601M	533M
Other Non Current Liabilities	503M	565M	706M	773M	773M
Total Liabilities	9.98B	9.73B	9.43B	9.1B	9.36B
Common Stock, Total	2M	2M	2M	2M	2M
Additional Paid In Capital	2.17B	2.19B	2.32B	2.37B	2.46B
Retained Earnings	8.08B	8.56B	8.97B	9.49B	10.01B
Treasury Stock	-3.96B	-4.86B	-5.93B	-6.08B	-6.38B
Comprehensive Income and Other	-273M	-182M	-205M	-319M	-314M
Total Common Equity	6.02B	5.7B	5.15B	5.46B	5.78B
Minority Interest	85M	84M	83M	72M	73M
Total Equity	6.11B	5.79B	5.24B	5.53B	5.85B
Total Liabilities And Equity	16.08B	15.52B	14.67B	14.63B	15.21B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	136M	129M	119M	117M	115M
ECS Total Common Shares Outstanding	136M	129M	119M	117M	115M
Book Value / Share	44.33	44.25	43.4	46.53	50.2
Tangible Book Value	-234M	701M	279M	674M	1.12B
Tangible Book Value Per Share	-1.72	5.44	2.35	5.75	9.69
Total Debt	5.85B	5.37B	5.35B	5.08B	5.22B
Net Debt	5.28B	4.89B	4.86B	4.53B	4.36B
Debt Equivalent of Unfunded Proj. Benefit Obligation	403M	39M	79M	142M	87M
Debt Equivalent Oper. Leases	848M	856M	792M	840M	848M
Minority Interest, Total (Incl. Fin. Div)	85M	84M	83M	72M	73M
Equity Method Investments, Total	111M	96M	111M	106M	114M
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-226M	-365M	-493M	-421M	-375M
Inventories - Raw Materials, Total	511M	589M	743M	618M	737M
Inventories - Work In Process, Total	203M	273M	297M	293M	305M
Inventories - Finished Goods, Total	891M	1.01B	1.35B	1.19B	1.32B
Land - (BS)	163M	150M	140M	114M	111M
Buildings, Total	1.82B	1.46B	1.39B	1.48B	1.53B
Machinery, Total	11.49B	10.45B	10.54B	10.75B	11.57B
Full Time Employees	14.5K	14K	14.5K	14K	14K
Accumulated Allowance for Doubtful Accounts (Supple)	14M	17M	15M	17M	15M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	478M	857M	793M	894M	905M
Depreciation & Amortization - CF	438M	430M	390M	389M	427M
Amortization of Goodwill and Intangible Assets - (CF)	128M	108M	87M	86M	82M
Depreciation & Amortization, Total	566M	538M	477M	475M	509M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	552M	58M	-338M	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	154M	16M	-	23M	5M
Other Operating Activities, Total	141M	-294M	-114M	-47M	-103M
Change In Accounts Receivable	-31M	-281M	93M	126M	28M
Change In Inventories	291M	-389M	-430M	201M	-344M
Change In Accounts Payable	-100M	554M	60M	-190M	188M
Change in Other Net Operating Assets	-44M	66M	38M	230M	99M
Cash from Operations	1.46B	1.62B	975M	1.37B	1.29B
Capital Expenditure	-383M	-555M	-611M	-828M	-599M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-1M	-114M	-1M	-77M	-
Divestitures	-	667M	998M	456M	38M
Sale (Purchase) of Intangible assets	-	-23M	-13M	-5M	-
Other Investing Activities, Total	-10M	-4M	19M	22M	27M
Cash from Investing	-394M	-29M	392M	-432M	-534M
Short Term Debt Issued, Total	-	-	326M	-	-
Long-Term Debt Issued, Total	249M	-	500M	796M	1.24B
Total Debt Issued	249M	-	826M	796M	1.24B
Short Term Debt Repaid, Total	-121M	-50M	-	-326M	-
Long-Term Debt Repaid, Total	-435M	-300M	-750M	-808M	-1.04B
Total Debt Repaid	-556M	-350M	-750M	-1.13B	-1.04B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-60M	-1B	-1B	-150M	-300M
Common Dividends Paid	-358M	-375M	-381M	-376M	-379M
Common & Preferred Stock Dividends Paid	-358M	-375M	-381M	-376M	-379M
Other Financing Activities, Total	21M	35M	-14M	-24M	27M
Cash from Financing	-704M	-1.69B	-1.32B	-888M	-454M
Foreign Exchange Rate Adjustments	3M	-5M	-12M	1M	-10M
Net Change in Cash	360M	-105M	34M	55M	289M
Supplemental Items
Cash Interest Paid	191M	170M	179M	214M	203M
Cash Income Tax Paid (Refund)	179M	122M	78M	158M	111M
Levered Free Cash Flow	918M	422M	1.38B	444M	551M
Unlevered Free Cash Flow	1.05B	548M	1.5B	585M	686M
Change In Net Working Capital	-210M	649M	-776M	-210M	151M
Net Debt Issued / Repaid	-307M	-350M	76M	-338M	198M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.83	7.38	5.33	4.56	5.79
Return on Total Capital	5.13	10.1	7.4	6.36	8.04
Return On Equity %	8.06	14.58	14.44	16.64	15.96
Return on Common Equity	7.98	14.62	14.61	16.85	16.11
Margin Analysis
Gross Profit Margin %	23.4	23.9	20.57	22.54	24.48
SG&A Margin	9.12	3.66	5.91	8.34	7.08
EBITDA Margin %	18.29	22.96	16.67	16.76	20.17
EBITA Margin %	13.12	18.85	12.99	12.54	15.62
EBIT Margin %	11.61	17.82	12.16	11.61	14.74
Income From Continuing Operations Margin %	5.77	8.28	7.52	9.73	9.68
Net Income Margin %	5.64	8.18	7.5	9.71	9.65
Net Avail. For Common Margin %	5.64	8.18	7.5	9.71	9.65
Normalized Net Income Margin	5.52	9.96	6.5	5.52	7.54
Levered Free Cash Flow Margin	10.84	4.03	13.09	4.83	5.88
Unlevered Free Cash Flow Margin	12.42	5.23	14.2	6.35	7.32
Asset Turnover
Asset Turnover	0.53	0.66	0.7	0.63	0.63
Fixed Assets Turnover	1.47	1.91	2	1.66	1.63
Receivables Turnover (Average Receivables)	7.92	9.24	9.52	9.42	10.49
Inventory Turnover (Average Inventory)	4.27	5.53	4.95	3.99	3.86
Short Term Liquidity
Current Ratio	1.74	1.56	1.16	1.35	1.51
Quick Ratio	1.02	0.69	0.54	0.66	0.75
Operating Cash Flow to Current Liabilities	0.71	0.54	0.3	0.53	0.48
Days Sales Outstanding (Average Receivables)	46.22	39.51	38.35	38.76	34.9
Days Outstanding Inventory (Average Inventory)	85.75	66	73.79	91.51	94.82
Average Days Payable Outstanding	49.8	45.69	52.86	65.61	61.39
Cash Conversion Cycle (Average Days)	82.17	59.82	59.28	64.65	68.33
Long Term Solvency
Total Debt/Equity	95.74	92.8	102.23	91.84	89.2
Total Debt / Total Capital	48.91	48.13	50.55	47.87	47.15
LT Debt/Equity	89.11	79.03	79.74	81.12	80.6
Long-Term Debt / Total Capital	45.53	40.99	39.43	42.28	42.6
Total Liabilities / Total Assets	62.02	62.7	64.3	62.21	61.53
EBIT / Interest Expense	4.6	9.29	6.85	4.75	6.4
EBITDA / Interest Expense	7.74	12.5	9.91	7.33	9.25
(EBITDA - Capex) / Interest Expense	5.95	9.74	6.66	3.65	6.48
Total Debt / EBITDA	3.53	2.14	2.87	3.08	2.61
Net Debt / EBITDA	3.19	1.95	2.61	2.75	2.18
Total Debt / (EBITDA - Capex)	4.59	2.74	4.28	6.19	3.73
Net Debt / (EBITDA - Capex)	4.15	2.5	3.88	5.52	3.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.63	23.64	0.99	-12.95	1.87
Gross Profit, 1 Yr. Growth %	-11.24	26.27	-13.1	-4.6	10.65
EBITDA, 1 Yr. Growth %	-16.67	54.36	-26.65	-12.47	22.54
EBITA, 1 Yr. Growth %	-21.08	77.61	-30.43	-15.94	26.84
EBIT, 1 Yr. Growth %	-21.22	89.74	-31.07	-16.94	29.37
Earnings From Cont. Operations, 1 Yr. Growth %	-35.83	77.3	-8.19	12.56	1.34
Net Income, 1 Yr. Growth %	-37.02	79.29	-7.47	12.74	1.23
Normalized Net Income, 1 Yr. Growth %	-26.86	123.14	-34.12	-26.12	39.17
Diluted EPS Before Extra, 1 Yr. Growth %	-36.13	78.57	1.6	17.95	2.4
Accounts Receivable, 1 Yr. Growth %	4.78	7.12	-10.49	-13.71	-2.54
Inventory, 1 Yr. Growth %	-17.03	9.06	25.93	-11.14	18.12
Net Property, Plant and Equip., 1 Yr. Growth %	-0.75	-9.1	3.05	6.65	0.89
Total Assets, 1 Yr. Growth %	0.47	-3.51	-5.49	-0.23	3.96
Tangible Book Value, 1 Yr. Growth %	-51.65	-399.57	-60.2	141.58	65.43
Common Equity, 1 Yr. Growth %	1.09	-5.3	-9.66	5.92	5.88
Cash From Operations, 1 Yr. Growth %	-3.26	11.27	-39.78	40.92	-6.33
Capital Expenditures, 1 Yr. Growth %	-9.88	44.91	10.09	35.52	-27.66
Levered Free Cash Flow, 1 Yr. Growth %	6.22	-53.76	224.14	-69.06	8.01
Unlevered Free Cash Flow, 1 Yr. Growth %	4.92	-47.67	171.74	-62.36	5.41
Dividend Per Share, 1 Yr. Growth %	5.95	5.99	8.48	3.58	2.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-8.64	6.29	11.74	-6.24	-5.83
Gross Profit, 2 Yr. CAGR %	-10.56	5.87	4.75	-8.95	3.68
EBITDA, 2 Yr. CAGR %	-15.19	13.71	6.41	-19.88	4.73
EBITA, 2 Yr. CAGR %	-19.48	18.39	11.16	-23.53	4.76
EBIT, 2 Yr. CAGR %	-20.35	22.26	14.36	-24.33	5.27
Earnings From Cont. Operations, 2 Yr. CAGR %	-32.84	6.67	27.59	1.66	6.8
Net Income, 2 Yr. CAGR %	-33.47	6.26	28.8	2.14	6.83
Normalized Net Income, 2 Yr. CAGR %	-24.43	27.76	21.25	-30.24	3.25
Diluted EPS Before Extra, 2 Yr. CAGR %	-31.96	6.79	34.7	9.47	9.9
Accounts Receivable, 2 Yr. CAGR %	-5.11	5.95	-2.08	-12.12	-8.3
Inventory, 2 Yr. CAGR %	-6.67	-4.87	17.19	5.78	2.45
Net Property, Plant and Equip., 2 Yr. CAGR %	1.11	-4.94	-3.22	4.83	3.73
Total Assets, 2 Yr. CAGR %	0.27	-1.54	-4.5	-2.9	1.84
Tangible Book Value, 2 Yr. CAGR %	-47.5	20.35	9.19	-1.94	99.91
Common Equity, 2 Yr. CAGR %	1.88	-2.15	-7.5	-2.18	5.9
Cash From Operations, 2 Yr. CAGR %	-2.89	3.75	-18.14	-7.88	14.89
Capital Expenditures, 2 Yr. CAGR %	-14.83	14.28	26.31	22.14	-0.99
Levered Free Cash Flow, 2 Yr. CAGR %	7.63	-29.87	22.98	1.78	-37.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	5.71	-25.86	19.79	2.88	-33.3
Dividend Per Share, 2 Yr. CAGR %	7.74	5.97	7.23	6	3.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.91	1.06	4.49	2.82	-3.61
Gross Profit, 3 Yr. CAGR %	-7.12	0.34	-0.87	1.54	-2.84
EBITDA, 3 Yr. CAGR %	-11.56	3.73	-1.75	-0.3	-7.69
EBITA, 3 Yr. CAGR %	-15.11	4.82	-0.84	1.27	-9.48
EBIT, 3 Yr. CAGR %	-15.9	6.38	1	2.8	-9.52
Earnings From Cont. Operations, 3 Yr. CAGR %	-29.37	-7.18	1.47	22.37	1.55
Net Income, 3 Yr. CAGR %	-29.84	-7.42	1.47	23.21	1.83
Normalized Net Income, 3 Yr. CAGR %	-19.01	8.41	2.45	2.79	-12.18
Diluted EPS Before Extra, 3 Yr. CAGR %	-28.24	-6.15	5.03	28.87	7.06
Accounts Receivable, 3 Yr. CAGR %	0.84	-1.19	0.16	-6.12	-9.03
Inventory, 3 Yr. CAGR %	-2.96	-1.69	4.45	6.87	9.75
Net Property, Plant and Equip., 3 Yr. CAGR %	0.7	-2.36	-2.35	-0.03	3.5
Total Assets, 3 Yr. CAGR %	0.17	-1	-2.87	-3.1	-0.66
Tangible Book Value, 3 Yr. CAGR %	-46.13	-6.19	-16.78	42.28	16.73
Common Equity, 3 Yr. CAGR %	3.69	-0.57	-4.72	-3.23	0.44
Cash From Operations, 3 Yr. CAGR %	-4.24	1.62	-13.45	-1.89	-7.36
Capital Expenditures, 3 Yr. CAGR %	-16.12	1.68	12.86	29.3	2.58
Levered Free Cash Flow, 3 Yr. CAGR %	10.46	-18.93	17.28	-21.41	8.71
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.06	-16.51	14.66	-17.63	7.48
Dividend Per Share, 3 Yr. CAGR %	8.51	7.16	6.8	6	4.83
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.56	3.07	2.07	-1.93	0.23
Gross Profit, 5 Yr. CAGR %	-5.18	1.22	-2.54	-3.49	0.56
EBITDA, 5 Yr. CAGR %	-6.53	3.56	-4.67	-6.45	0.34
EBITA, 5 Yr. CAGR %	-8.83	4.24	-5.45	-7.6	0.78
EBIT, 5 Yr. CAGR %	-9.29	5.35	-4.89	-7.17	2.06
Earnings From Cont. Operations, 5 Yr. CAGR %	-10.55	0.19	-10.52	-3.74	3.57
Net Income, 5 Yr. CAGR %	-10.83	0.07	-10.54	-3.71	3.58
Normalized Net Income, 5 Yr. CAGR %	-10.96	7.41	-4.82	-9.11	2.03
Diluted EPS Before Extra, 5 Yr. CAGR %	-9.17	1.68	-7.68	-0.19	6.96
Accounts Receivable, 5 Yr. CAGR %	6.69	7.63	-0.34	-5.72	-3.31
Inventory, 5 Yr. CAGR %	-1.39	1.39	4.65	1.23	3.65
Net Property, Plant and Equip., 5 Yr. CAGR %	2.22	-0.24	-0.86	0.45	0.04
Total Assets, 5 Yr. CAGR %	0.64	0.08	-1.72	-1.76	-1.01
Tangible Book Value, 5 Yr. CAGR %	-40.83	-21.87	-28.54	-4.51	18.16
Common Equity, 5 Yr. CAGR %	8.85	4.71	-0.94	-1.22	-0.61
Cash From Operations, 5 Yr. CAGR %	-2.17	3.17	-10.06	-2.29	-3.07
Capital Expenditures, 5 Yr. CAGR %	-10.09	-2.38	-1.2	9.42	7.1
Levered Free Cash Flow, 5 Yr. CAGR %	-2.98	-3.94	15.24	-10.92	-8.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	-3.14	-4.15	12.5	-9.07	-7.19
Dividend Per Share, 5 Yr. CAGR %	9.97	8.41	7.99	6.69	5.28